We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Expands Autoimmune Therapy Reach With $1.85 Billion Pandion Purchase
Merck Expands Autoimmune Therapy Reach With $1.85 Billion Pandion Purchase
Merck plans to acquire Massachusetts-based Pandion Therapeutics for an estimated $1.85 billion to broaden its portfolio of autoimmune disease therapies.